Andria L. Del Tredici

Myriad Genetics — United States

Pharmacology, Toxicology and Pharmaceutics · Life Sciences

18h-index1.4kcitations37works4.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Pharmacogenetics and Drug Metabolism(14), Estrogen and related hormone effects(6), Pharmaceutical studies and practices(6), Receptor Mechanisms and Signaling(5), Drug Transport and Resistance Mechanisms(4)

Publications37 total

Persistent benefit of pharmacogenomic testing on initial remission and response rates in patients with major depressive disorder
Frontiers in Pharmacology·2025· 1 citedOpen Access
Meta-analysis of Response and Remission Outcomes With a Weighted Multigene Pharmacogenomic Test for Adults With Depression
Journal of Clinical Psychopharmacology·2025· 3 citedOpen Access
Real-world pharmacotherapy treatment patterns among patients diagnosed with postpartum depression in the United States
BMC Psychiatry·2025· 1 citedOpen Access
Real-World Impact of Pharmacogenomic Testing on Medication Use and Healthcare Resource Utilization in Patients With Major Depressive Disorder
Journal of Clinical Psychopharmacology·2025· 7 citedOpen Access
Integrating Pharmacogenomics into the Broader Construct of Genomic Medicine: Efforts by the ClinGen Pharmacogenomics Working Group (PGxWG)
Clinical Chemistry·2025· 11 citedOpen Access
Impact of genetic variation in CYP2C19, CYP2D6, and CYP3A4 on oxycodone and its metabolites in a large database of clinical urine drug tests
The Pharmacogenomics Journal·2021· 2 cited
PharmVar GeneFocus: <i>CYP2C9</i>
Clinical Pharmacology & Therapeutics·2021· 70 citedOpen Access
Recommendations for Clinical CYP2D6 Genotyping Allele Selection
Journal of Molecular Diagnostics·2021· 142 citedOpen Access
&lt;p&gt;Genetic Testing for &lt;em&gt;BCHE&lt;/em&gt; Variants Identifies Patients at Risk of Prolonged Neuromuscular Blockade in Response to Succinylcholine&lt;/p&gt;
Pharmacogenomics and Personalized Medicine·2020· 9 citedOpen Access
PharmVar GeneFocus: <i>CYP2C19</i>
Clinical Pharmacology & Therapeutics·2020· 132 citedOpen Access
Recommendations for Clinical Warfarin Genotyping Allele Selection
Journal of Molecular Diagnostics·2020· 65 citedOpen Access
Ambiguous pharmacogenetic genotyping results in a patient with bone marrow transplantation
Journal of Laboratory Medicine·2019· 1 citedOpen Access
Recommendations for Clinical CYP2C9 Genotyping Allele Selection
Journal of Molecular Diagnostics·2019· 131 citedOpen Access
A Screening Test for HLA-B∗15:02 in a Large United States Patient Cohort Identifies Broader Risk of Carbamazepine-Induced Adverse Events
Frontiers in Pharmacology·2019· 25 citedOpen Access
Recommendations for Clinical CYP2C9 Genotyping Allele Selection: A Joint Recommendation of the Association for Molecular Pathology and College of American Pathologists
Publisher·2019· 19 cited
Frequency of CYP2D6 Alleles Including Structural Variants in the United States
Frontiers in Pharmacology·2018· 124 citedOpen Access
Recommendations for Clinical CYP2C19 Genotyping Allele Selection
Journal of Molecular Diagnostics·2018· 201 citedOpen Access
Recommendations for Clinical CYP2C19 Genotyping Allele Selection: A Report of the Association for Molecular Pathology
Author eBooks·2018· 36 cited
Genotypes at rs2844682 and rs3909184 have no clinical value in identifying HLA-B*15:02 carriers
European Journal of Clinical Pharmacology·2015· 6 cited
Identification of the Antiarrhythmic Drugs Amiodarone and Lorcainide as Potent H3 Histamine Receptor Inverse Agonists
Journal of Pharmacology and Experimental Therapeutics·2013· 3 cited
page 1 of 2Next →

Frequent Co-authors

Fabrice Piu(14), Roger Olsson(10), Stuart A. Scott(9), Victoria M. Pratt(8), Ethan S. Burstein(8), Mark R. Brann(8), Erika A. Currier(8), Hans H. Schiffer(7), Michelle Whirl‐Carrillo(7), Houda Hachad(6), Yuan Ji(6), Karen E. Weck(6), Luis R. Gardell(6), Larisa H. Cavallari(6), Carsten Andersen(6), Ann M. Moyer(5), Lisa V. Kalman(4), Jelveh Lameh(4), Andrea Gaedigk(4), Frank G. Espin(4)